Related Experiment Video

Updated: May 21, 2026

Using Next Generation Sequencing to Identify Mutations Associated with Repair of a CAS9-induced Double Strand Break Near the CD4 Promoter
06:59

Using Next Generation Sequencing to Identify Mutations Associated with Repair of a CAS9-induced Double Strand Break Near the CD4 Promoter

Published on: March 31, 2022

Modulation of DNA repair genes induced by TLR9 agonists: A strategy to eliminate "altered" cells?

Michele Sommariva1, Loris De Cecco, Elda Tagliabue

  • 1Department of Human Morphology and Biomedical Sciences "Città Studi"; Università degli Studi di Milano; Milan, Italy ; Molecular Targeting Unit Fondazione IRCCS; Istituto Nazionale Tumori; Milan, Italy.

Oncoimmunology
|June 22, 2012
PubMed

Insights

CpG-oligodeoxynucleotide (CpG-ODN) therapy engages Toll-like receptor 9 (TLR9) on immune cells, reducing DNA repair gene expression in cancer cells. This enhances chemotherapy effectiveness, offering benefits beyond immune stimulation.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Toll-like receptor 9 (TLR9) agonists like CpG-oligodeoxynucleotide (CpG-ODN) are known for stimulating immune responses.
  • The tumor microenvironment (TME) contains innate immune cells that can be targeted by TLR9 agonists.
  • Cancer cells possess DNA repair mechanisms that contribute to chemotherapy resistance.

Purpose of the Study:

  • To investigate the effect of TLR9 engagement by CpG-ODN on DNA repair gene expression in tumor cells.
  • To determine if this modulation sensitizes cancer cells to DNA-damaging chemotherapy.
  • To explore novel therapeutic applications of CpG-ODN beyond immune stimulation.

Main Methods:

  • Treatment of tumor cells and TME-resident immune cells with CpG-ODN.
  • Analysis of DNA repair gene expression in tumor cells using molecular techniques.
  • Assessment of cancer cell sensitivity to chemotherapy post-CpG-ODN treatment.

Main Results:

  • CpG-ODN engagement of TLR9 on innate immune cells down-modulated DNA repair gene expression in adjacent tumor cells.
  • This down-regulation of DNA repair mechanisms sensitized cancer cells to DNA-damaging chemotherapy.
  • CpG-ODN demonstrated a dual role, impacting both immune response and tumor cell intrinsic pathways.

Conclusions:

  • TLR9 activation by CpG-ODN in the TME offers a strategy to overcome chemotherapy resistance by inhibiting DNA repair in cancer cells.
  • CpG-ODN therapy presents a promising approach to enhance the efficacy of conventional chemotherapy.
  • These findings broaden the therapeutic potential of CpG-ODN in cancer treatment.

More Related Videos

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage10:59

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage

Published on: August 21, 2021

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

Related Concept Videos

Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair01:36

Mismatch Repair

Overview
Translesion DNA Polymerases02:10

Translesion DNA Polymerases

Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...